Literature DB >> 12902521

Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis.

Jun-Qi Yang1, Avneesh K Singh, Michael T Wilson, Minoru Satoh, Aleksandar K Stanic, Jang-June Park, Seokmann Hong, Stephan D Gadola, Akiei Mizutani, Srinivasa R Kakumanu, Westley H Reeves, Vincenzo Cerundolo, Sebastian Joyce, Luc Van Kaer, Ram Raj Singh.   

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that is accompanied by the emergence of autoreactive T cells and a reduction in regulatory T cells. Humans and mice with SLE have reduced numbers of CD1d-restricted NK T cells, suggesting a role for these cells in the regulation of SLE. In this study, we show that CD1d deficiency exacerbates lupus nephritis induced by the hydrocarbon oil pristane. This exacerbation in disease is associated with: 1) reduced TNF-alpha and IL-4 production by T cells, especially during the disease induction phase; and 2) expansion of marginal zone B cells. Strikingly, inoculation of pristane in wild-type mice resulted in reduced numbers and/or functions of NK T cells and CD1d-expressing dendritic cells. These findings suggest that CD1d may play an immunoregulatory role in the development of lupus in the pristane-induced model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902521     DOI: 10.4049/jimmunol.171.4.2142

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

Review 1.  Going both ways: immune regulation via CD1d-dependent NKT cells.

Authors:  Dale I Godfrey; Mitchell Kronenberg
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

2.  MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis.

Authors:  Caroline G McPhee; Thomas J Sproule; Dong-Mi Shin; Jason A Bubier; William H Schott; Martin P Steinbuck; Lia Avenesyan; Herbert C Morse; Derry C Roopenian
Journal:  J Immunol       Date:  2011-09-30       Impact factor: 5.422

3.  Brief treatment with iNKT cell ligand α-galactosylceramide confers a long-term protection against lupus.

Authors:  Jun-Qi Yang; Peter J Kim; Ram Raj Singh
Journal:  J Clin Immunol       Date:  2011-10-15       Impact factor: 8.317

Review 4.  SLE: translating lessons from model systems to human disease.

Authors:  Ram Raj Singh
Journal:  Trends Immunol       Date:  2005-09-09       Impact factor: 16.687

5.  Disparate effects of depletion of CD1d-reactive T cells during early versus late stages of disease in a genetically susceptible model of lupus.

Authors:  J Jacinto; P J Kim; R R Singh
Journal:  Lupus       Date:  2011-11-07       Impact factor: 2.911

Review 6.  The role of invariant natural killer T cells in lupus and atherogenesis.

Authors:  Amy S Major; Ram R Singh; Sebastian Joyce; Luc Van Kaer
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

7.  Natural killer T cells and innate immune B cells from lupus-prone NZB/W mice interact to generate IgM and IgG autoantibodies.

Authors:  Tsuyoshi Takahashi; Samuel Strober
Journal:  Eur J Immunol       Date:  2008-01       Impact factor: 5.532

8.  Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritis.

Authors:  Laurent Mesnard; Alexandre C Keller; Marie-Laure Michel; Sophie Vandermeersch; Cédric Rafat; Emmanuel Letavernier; Yves Tillet; Eric Rondeau; Maria C Leite-de-Moraes
Journal:  J Am Soc Nephrol       Date:  2009-05-21       Impact factor: 10.121

9.  NKT cells inhibit the development of experimental crescentic glomerulonephritis.

Authors:  Seung Hee Yang; Su Jin Kim; Nakkyung Kim; Ji Eun Oh; Jung Gil Lee; Nam Hyun Chung; Suhnggwon Kim; Yon Su Kim
Journal:  J Am Soc Nephrol       Date:  2008-06-04       Impact factor: 10.121

10.  Role of 2B4-mediated signals in the pathogenesis of a murine hepatitis model independent of Fas and Valpha14 NKT cells.

Authors:  Hiroshi Furukawa; Hiroshi Kitazawa; Izumi Kaneko; Mitsunobu Matsubara; Masato Nose; Masao Ono
Journal:  Immunology       Date:  2008-09-17       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.